Review Article
Volume 9 Issue 12 - 2020
Adderall: On the Razor’s Edge of ADHD Treatment, Enhanced Academic and Physical Performance, Addiction, Psychosis, and Death
Nicholas A Kerna1,2*, John V Flores3,4, Hilary M Holets2,5, Uzoamaka Nwokorie5, Kevin D Pruitt6, Emmanuella Solomon7 and Kyle Kadivi8
1SMC–Medical Research, Thailand
2First InterHealth Group, Thailand
3Beverly Hills Wellness Surgical Institute, USA
4Orange Partners Surgicenter, USA
5University of Washington, USA
6Kemet Medical Consultants, USA
7Obafemi Awolowo University, Nigeria
8Global Health Group LLC, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: October 14, 2020; Published: November 30, 2020




Abstract

Adderall, as a drug combination, is medically-approved for treating attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The active ingredients of Adderall are central nervous system stimulants, affecting neurotransmitters and promoting the synthesis of specific neuropeptides. Pharmacological effects include increased physical energy, improved mental aptitude, hyperexcitability, and mood elevation. In ADHD, Adderall increases arousal, wakefulness, and motivation to execute a task, promoting goaldirected behavior. Regarding physical performance, amphetamine (Adderall) improves endurance and reaction time. Thus, Adderall is banned for use among professional and Olympic athletes. As well as benefits, Adderall has numerous mild to severe adverse effects (including death) and can result in physical and psychological dependence. The sudden cessation of the drug may cause paranoid delusion, psychosis, hallucinations, mood swings, suicidal ideation, panic attack, and tremor. Also, long-term use can result in tolerance to the drug. Adderall has high abuse potential as a recreational agent. It is misused as an academic-enhancer—known as “smart pills”—by students. Although medically-approved for managing symptoms of ADHD and in treating narcolepsy, Adderall has a high abuse and addiction potential and should be taken only if medically prescribed. Realistically, however, Adderall’s off-label and unprescribed use will likely continue; if so, it should be taken with extreme caution and vigilance..

Keywords: Amphetamine; Attention; Cocaine; Dopamine; Ecstasy; Hyperactive; Neurotransmitter; Smart Pills

References

  1. Heal DJ., et al. “Amphetamine, past and present - A pharmacological and clinical perspective”. Journal of Psychopharmacology6 (2013): 479-496.
  2. Joyce BM., et al. “Adderall® produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers”. Psychopharmacology 3 (2007): 669-677. https://pubmed.ncbi.nlm.nih.gov/17031708/
  3. Administration USF Drugs. “Adderall XR Prescribing Information”. Interactions (1998).
  4. Mayer FP., et al. “An unsuspected role for organic cation transporter 3 in the actions of amphetamine”. Neuropsychopharmacology (2018). https://www.nature.com/articles/s41386-018-0053-5
  5. Miller GM. “The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity”. Journal of Neurochemistry2 (2011): 164-176. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101/
  6. National Drug Code Directory. National Drug Code Amphetamine Search Results.
  7. Spencer RC., et al. “The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex”. Biological Psychiatry (2015): 940-950. https://pubmed.ncbi.nlm.nih.gov/25499957/
  8. Wood S., et al. “Psychostimulants and cognition: A continuum of behavioral and cognitive activation”. Pharmacological Reviews1 (2014): 193-221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463/
  9. Malenka RC and Nestler EJ HSE. “Neural and Neuroendocrine Control of the Internal Milieu”. In: Sydor A BRY, ed. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience”. 2nd edition. McGraw-Hill Medical (2009): 266. https://neurology.mhmedical.com/content.aspx?bookid=1204&sectionid=72649862
  10. Teter CJ., et al. “Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration”. Pharmacotherapy10 (2006): 1501-1510. https://pubmed.ncbi.nlm.nih.gov/16999660/
  11. Weyandt LL., et al. “Pharmacological interventions for adolescents and adults with ADHD: Stimulant and nonstimulant medications and misuse of prescription stimulants”. Psychology Research and Behavior Management (2014): 223-249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164338/
  12. Malenka RC and Nestler EJ HSE. “Higher Cognitive Function and Behavioral Control”. In: Sydor A B, ed. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience”. 2nd edition. McGraw-Hill Medical (2009): 318. https://neurology.mhmedical.com/content.aspx?bookid=1204&sectionid=72650248
  13. Bagot KS and Kaminer Y. “Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: A systematic review”. Addiction 4 (2014): 547-557. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471173/
  14. Parr JW. “Attention-deficit hyperactivity disorder and the athlete: New advances and understanding”. Clinics in Sports Medicine3 (2011): 591-610. https://pubmed.ncbi.nlm.nih.gov/21658550/
  15. Roelands B., et al. “Neurophysiological determinants of theoretical concepts and mechanisms involved in pacing”. Sports Medicine5 (2013): 301-311. https://pubmed.ncbi.nlm.nih.gov/23456493/
  16. Meeusen R and Roelands B. “Central fatigue and neurotransmitters, can thermoregulation be manipulate”. Scandinavian Journal of Medical Science in Sports3 (2010): 19-28. https://pubmed.ncbi.nlm.nih.gov/21029187/
  17. Docherty JR. “Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)”. British Journal of Pharmacology3 (2008): 606-622. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2439527/
  18. Avois L., et al. “Central nervous system stimulants and sport practice”. British Journal of Sports Medicine 1.1 (2006): i16-20. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657493/
  19. Weston Maureen A. “The Regulation of Doping in U.S. And International Sports (2017). Michael McCann, ed., Handbook on Sports Law, Oxford University Press (2017), Pepperdine University Legal Studies Research (2017). https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2951899
  20. Berman SM., et al. “Potential adverse effects of amphetamine treatment on brain and behavior: a review”. Molecular Psychiatry 2 (2009): 123-142. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670101/
  21. Mladěnka P., et al. “TOX-OER and CARDIOTOX Hradec Králové Researchers and Collaborators. Comprehensive review of cardiovascular toxicity of drugs and related agents”. Medicinal Research Reviews 4 (2018): 1332-1403. https://onlinelibrary.wiley.com/doi/full/10.1002/med.21476
  22. Sinha A., et al. “Amphetamine Abuse Related Acute Myocardial Infarction”. Case Reports in Cardiology (2016): 7967851. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779519/
  23. Berman SM., et al. “Potential adverse effects of amphetamine treatment on brain and behavior: a review”. Molecular Psychiatry 2 (2009): 123-142. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670101/
  24. Ackerman M., et al. “Sudden Cardiac Death in the Young”. Circulation10 (2016): 1006-1026. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.115.020254
  25. Farzam K., et al. “Sudden Death in Athletes”. In: Stat Pearls Treasure Island (FL): Stat Pearls Publishing (2020).
  26. Long Term Effects of Adderall on Brain, Personality, and Body. American Addiction Centers”. American Addiction Centers (2020). https://americanaddictioncenters.org/adderall/long-term-effects
  27. Yanofski J. “The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?” Innovations in Clinical Neuroscience 1 (2011): 47-53. https://pubmed.ncbi.nlm.nih.gov/21311708/
  28. Lakhan SE and Kirchgessner A. “Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects”. Brain and Behavior 5 (2012): 661-677. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489818/
  29. Smith ME and Farah MJ. “Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals”. Psychological Bulletin 5 (2011): 717-741. https://pubmed.ncbi.nlm.nih.gov/21859174/
  30. Puerta E and Aguirre N. “Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation”. Pharmaceuticals 4 (2011): 992-1018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058674/
  31. Moon KH., et al. “Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver”. Proteomics18 (2008): 3906-3918. https://pubmed.ncbi.nlm.nih.gov/18780394/
  32. Docherty JR. “Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)”. British Journal of Pharmacology 3 (2008): 606-622. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2439527/
Citation: Kerna NA, Flores JV, Holets HM, Nwokorie U, Pruitt KD, Solomon E, Kadivi K. Adderall: On the Razor’s Edge of ADHD Treatment, Enhanced Academic and Physical Performance, Addiction, Psychosis, and Death. EC Psychology and Psychiatry 9.12 (2020): 65-71.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk